A 'double-hit' bone marrow rare co-occurrence of 2 different pathologies

Area of Science:

• Hematology
• Oncology
• Cancer Research

Background:

• Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm.
• Chronic lymphocytic leukemia (CLL) is a lymphoid malignancy.
• Imatinib is a tyrosine kinase inhibitor used to treat CML.

Purpose of the Study:

• To report a rare case of sequential CML and CLL diagnoses in a single patient.
• To discuss the clinical implications and potential associations between these two distinct leukemias.

Main Methods:

• Case report detailing patient diagnosis and treatment history.
• Review of relevant medical literature on co-occurring or sequential leukemia diagnoses.

Main Results:

• The patient was diagnosed with CML, treated with imatinib.
• Six months later, the patient was diagnosed with CLL.
• This sequence represents an unusual clinical presentation.

Conclusions:

• The occurrence of CLL after CML diagnosis warrants further investigation into potential shared risk factors or treatment-related effects.
• Close monitoring for secondary hematologic malignancies is crucial in patients with leukemia.